124 related articles for article (PubMed ID: 22768744)
21. Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.
Erlandson KM; Gudza I; Fiorillo S; Ndemera B; Schooley RT; Gwanzura L; Borok M; Campbell TB
Int J Infect Dis; 2014 Jul; 24():6-10. PubMed ID: 24769175
[TBL] [Abstract][Full Text] [Related]
22. [HIV plus hepatitis C or Kaposi sarcoma. Treatment options in coinfection].
MMW Fortschr Med; 2000 Mar; 142 Suppl 1():58-9. PubMed ID: 10863315
[No Abstract] [Full Text] [Related]
23. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.
Wit FW; Sol CJ; Renwick N; Roos MT; Pals ST; van Leeuwen R; Goudsmit J; Reiss P
AIDS; 1998 Jan; 12(2):218-9. PubMed ID: 9468373
[No Abstract] [Full Text] [Related]
24. Is switching protease inhibitor-based effective antiretroviral therapy safe in patients with AIDS-associated Kaposi's sarcoma?
Ridolfo AL; Corbellino M; Tosca N; Capelletti A; Scalamogna C; Galli M; Parravicini C
AIDS; 2004 May; 18(8):1224-6. PubMed ID: 15166546
[No Abstract] [Full Text] [Related]
25. Chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Pechère M; Krischer J; Rutschmann OT
Dermatology; 1997; 195(4):411-2. PubMed ID: 9529573
[No Abstract] [Full Text] [Related]
26. Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma.
Schwartz JD; Howard W; Scadden DT
AIDS; 1999 Feb; 13(2):283-4. PubMed ID: 10202837
[No Abstract] [Full Text] [Related]
27. Unknown: Unusual exophytic nodule on the plantar foot.
Chambers C; Sharon V; Fazel N
Dermatol Online J; 2010 Apr; 16(4):11. PubMed ID: 20409418
[TBL] [Abstract][Full Text] [Related]
28. Treatment of HIV infection and its complications.
Polsky B
Clin Chest Med; 1996 Dec; 17(4):647-63. PubMed ID: 9016370
[TBL] [Abstract][Full Text] [Related]
29. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
[TBL] [Abstract][Full Text] [Related]
30. Gingival involvement in a case series of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
Kalpidis CD; Lysitsa SN; Lombardi T; Kolokotronis AE; Antoniades DZ; Samson J
J Periodontol; 2006 Mar; 77(3):523-33. PubMed ID: 16512768
[TBL] [Abstract][Full Text] [Related]
31. Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma.
Reid EG; Suazo A; Lensing SY; Dittmer DP; Ambinder RF; Maldarelli F; Gorelick RJ; Aboulafia D; Mitsuyasu R; Dickson MA; Wachsman W;
Clin Cancer Res; 2020 Feb; 26(3):558-565. PubMed ID: 31624104
[TBL] [Abstract][Full Text] [Related]
32. Images in HIV/AIDS. Elephantiasis nostras verrucosa secondary to Kaposi sarcoma: a rare case.
Sathyakumar S; Suh JS; Sharp VL; Polsky B
AIDS Read; 2008 Feb; 18(2):81-2. PubMed ID: 18330034
[No Abstract] [Full Text] [Related]
33. Immune reconstitution in several forms.
Ball SC
AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
[No Abstract] [Full Text] [Related]
34. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
Fumagalli L; Zucchetti M; Parisi I; Viganò MG; Zecca B; Careddu A; D'Incalci M; Lazzarin A
Cancer Chemother Pharmacol; 2000; 45(6):495-501. PubMed ID: 10854138
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
36. Kaposi sarcoma incidence in Mozambique: national and regional estimates.
Meireles P; Albuquerque G; Vieira M; Foia S; Ferro J; Carrilho C; Lunet N
Eur J Cancer Prev; 2015 Nov; 24(6):529-34. PubMed ID: 25494288
[TBL] [Abstract][Full Text] [Related]
37. AIDS-related Kaposi sarcoma: the role of local therapy for a systemic disease.
Dezube BJ
Arch Dermatol; 2000 Dec; 136(12):1554-6. PubMed ID: 11115173
[No Abstract] [Full Text] [Related]
38. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A; Aboobaker J; Shaik F
Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
[TBL] [Abstract][Full Text] [Related]
40. Anti-cancer agents.
TreatmentUpdate; 1998 Jun; 10(4):1-6. PubMed ID: 11365440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
